Managed Care 13Fs: UnitedHealth, Elevance, Humana, CVS, Cigna

US-traded managed care equities form a distinctive healthcare insurance corner of institutional 13F positioning facing structural pressure. UnitedHealth Group (UNH, UnitedHealthcare plus Optum), Elevance Health (ELV, post-Anthem rebrand 2022), Humana (HUM, Medicare Advantage focus), CVS Health (CVS, Aetna plus Caremark PBM plus retail pharmacy), Cigna (CI, Evernorth services plus Cigna Healthcare), plus Centene (CNC, Medicaid focus) anchor the cohort. Multi-year emerging Medicare Advantage pressure, medical loss ratio dynamics, plus emerging emerging Optum-CVS pharmacy benefit manager scrutiny drive distinctive institutional positioning. Reading managed care 13F positioning requires understanding the segment framework plus the multi-year regulatory dynamics.

The managed care business model

Managed care companies operate four primary economic engines:

1. Medicare Advantage pressure. Multi-year emerging Medicare Advantage (MA) pressure drives multi-year emerging operator margin dynamics. Multi-year emerging CMS V28 risk adjustment changes (phased 2024-2026 implementation) plus emerging emerging emerging MA reimbursement rate (-0.16% 2024 effective rate plus emerging emerging emerging 2025 rate notice plus emerging emerging emerging emerging emerging 2026 rate notice) plus emerging emerging emerging emerging Stars rating dynamics drive multi-year emerging MA economics pressure.
2. Medical loss ratio dynamics. Multi-year emerging medical loss ratio (MLR) dynamics drives operator margin trajectory. Multi-year emerging post-pandemic medical utilization (deferred procedures emerging plus emerging emerging emerging GLP-1 drug utilization plus emerging emerging emerging behavioral health) drives MLR pressure. Multi-year emerging MLR exceeded historical 84-86% range to 88-90%+ at major operators (2024) plus emerging emerging emerging emerging emerging emerging emerging 2025 emerging emerging emerging emerging emerging stabilization emerging.
3. PBM scrutiny emerging. Multi-year emerging pharmacy benefit manager (PBM) scrutiny drives multi-year emerging operator strategic positioning. Multi-year emerging Optum Rx (UnitedHealth) plus CVS Caremark plus Express Scripts (Cigna Evernorth) plus emerging emerging FTC investigation (June 2022 launched) plus emerging emerging emerging emerging Congressional scrutiny plus emerging emerging emerging emerging state attorney general lawsuits plus emerging emerging emerging emerging proposed legislation drive multi-year emerging emerging PBM operator pressure.
4. Medicaid redetermination emerging. Multi-year emerging Medicaid redetermination emerging drives Centene plus emerging emerging operator economics. Multi-year emerging post-COVID Public Health Emergency (PHE) ended March 2023 plus emerging emerging Medicaid redetermination (~25M people disenrolled through 2024) plus emerging emerging emerging Centene Medicaid revenue decline plus emerging emerging emerging emerging emerging emerging managed Medicaid contract dynamics drive multi-year emerging operator economics.

Major US-traded managed care names

UnitedHealth Group (UNH)

Largest US managed care plus emerging emerging UnitedHealthcare (Commercial, Medicare & Retirement, Community & State Medicaid) plus emerging emerging Optum (OptumHealth, OptumInsight, OptumRx) plus emerging emerging Andrew Witty CEO leadership.

Elevance Health (ELV)

Diversified post-Anthem rebrand (2022) plus emerging emerging Health Benefits plus emerging emerging Carelon Services plus emerging emerging Carelon Rx PBM plus emerging emerging Gail Boudreaux CEO leadership.

Humana (HUM)

Diversified Medicare Advantage focus plus emerging emerging CenterWell senior primary care plus emerging emerging Healthcare Services plus emerging emerging Group Insurance plus emerging emerging Jim Rechtin CEO leadership transition (July 2024).

CVS Health (CVS)

Diversified Health Care Benefits (Aetna) plus emerging emerging Health Services (Caremark PBM plus Signify Health plus Oak Street Health primary care) plus emerging emerging Pharmacy & Consumer Wellness plus emerging emerging David Joyner CEO leadership transition (October 2024) post-Karen Lynch departure.

Cigna (CI)

Diversified Evernorth Health Services (Express Scripts PBM plus emerging emerging Accredo specialty) plus emerging emerging Cigna Healthcare plus emerging emerging David Cordani CEO leadership plus emerging emerging post-Medicare Advantage divestiture to HCSC (closed 2025).

Centene (CNC)

Diversified Medicaid focus plus emerging emerging Medicare Advantage plus emerging emerging Commercial Marketplace plus emerging emerging Sarah London CEO leadership.

How institutional managers position around managed care

Three patterns appear across smart-money 13Fs:

Pattern 1: Quality-leadership concentration

UNH-concentrated growth manager positions reflect quality managed care plus emerging emerging Optum diversification thesis.

Pattern 2: Turnaround positioning

HUM, CVS-concentrated value-discipline manager positions reflect MA recovery plus emerging emerging CVS operational restructuring thesis.

Pattern 3: Medicaid positioning

CNC-concentrated active manager positions reflect Medicaid redetermination plus emerging emerging emerging operational stabilization thesis.

How to read managed care 13F positioning

Three rules apply:

Rule 1: Identify segment exposure

Commercial vs Medicare Advantage vs Medicaid vs PBM have distinct dynamics.

Rule 2: Watch MLR trajectory

Multi-year MLR drives operator margins.

Rule 3: Cross-check MA reimbursement

Multi-year MA rate notices drive emerging emerging operator economics.

What managed care positioning signals

1. Quality-leadership conviction. Concentrated UNH positions signal quality managed care thesis.
2. Turnaround conviction. Concentrated HUM, CVS positions signal MA plus CVS turnaround thesis.
3. Medicaid conviction. Concentrated CNC positions signal Medicaid thesis.

For real-time tracking of managed care 13F activity, see the institutional signals feed.